Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Nature's Sunshine Products ROE 2010-2025 | NATR

Current and historical return on equity (ROE) values for Nature's Sunshine Products (NATR) over the last 10 years. Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
  
Nature's Sunshine Products ROE - Return on Equity Historical Data
Date TTM Net Income Shareholder's Equity Return on Equity
2025-03-31 $0.01B $0.17B 6.18%
2024-12-31 $0.01B $0.16B 4.38%
2024-09-30 $0.02B $0.16B 10.02%
2024-06-30 $0.02B $0.16B 9.55%
2024-03-31 $0.02B $0.16B 10.31%
2023-12-31 $0.02B $0.16B 9.87%
2023-09-30 $0.01B $0.15B 5.38%
2023-06-30 $0.01B $0.15B 3.42%
2023-03-31 $0.00B $0.15B 2.76%
2022-12-31 $0.00B $0.15B 0.00%
2022-09-30 $0.01B $0.14B 7.37%
2022-06-30 $0.02B $0.14B 10.61%
2022-03-31 $0.02B $0.15B 14.52%
2021-12-31 $0.03B $0.16B 19.43%
2021-09-30 $0.02B $0.15B 14.84%
2021-06-30 $0.02B $0.15B 16.19%
2021-03-31 $0.02B $0.14B 15.73%
2020-12-31 $0.02B $0.16B 15.25%
2020-09-30 $0.02B $0.15B 12.39%
2020-06-30 $0.01B $0.14B 8.33%
2020-03-31 $0.01B $0.13B 6.23%
2019-12-31 $0.01B $0.13B 5.57%
2019-09-30 $0.00B $0.13B 2.42%
2019-06-30 $0.00B $0.13B 2.44%
2019-03-31 $0.00B $0.12B 0.00%
2018-12-31 $0.00B $0.12B -1.64%
2018-09-30 $-0.02B $0.12B -13.17%
2018-06-30 $-0.02B $0.12B -12.02%
2018-03-31 $-0.02B $0.12B -11.74%
2017-12-31 $-0.01B $0.12B -9.92%
2017-09-30 $0.00B $0.14B -2.24%
2017-06-30 $0.00B $0.13B -0.74%
2017-03-31 $0.00B $0.13B 1.46%
2016-12-31 $0.00B $0.13B 1.45%
2016-09-30 $0.01B $0.14B 9.39%
2016-06-30 $0.01B $0.14B 8.78%
2016-03-31 $0.01B $0.14B 8.86%
2015-12-31 $0.02B $0.14B 11.90%
2015-09-30 $0.01B $0.14B 6.03%
2015-06-30 $0.01B $0.13B 4.50%
2015-03-31 $0.01B $0.13B 4.64%
2014-12-31 $0.01B $0.13B 8.02%
2014-09-30 $0.02B $0.14B 13.47%
2014-06-30 $0.02B $0.12B 18.06%
2014-03-31 $0.02B $0.12B 20.54%
2013-12-31 $0.02B $0.11B 15.93%
2013-09-30 $0.02B $0.11B 17.28%
2013-06-30 $0.02B $0.12B 17.87%
2013-03-31 $0.02B $0.12B 19.56%
2012-12-31 $0.02B $0.12B 22.48%
2012-09-30 $0.03B $0.11B 28.14%
2012-06-30 $0.02B $0.10B 21.86%
2012-03-31 $0.02B $0.10B 21.90%
2011-12-31 $0.02B $0.09B 23.24%
2011-09-30 $0.01B $0.08B 12.99%
2011-06-30 $0.01B $0.08B 8.14%
2011-03-31 $0.00B $0.08B 1.45%
2010-12-31 $0.00B $0.07B -3.05%
2010-09-30 $0.00B $0.07B 4.78%
2010-06-30 $0.01B $0.06B 18.57%
2010-03-31 $0.01B $0.06B 21.43%
2009-12-31 $0.01B $0.06B 13.33%
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.269B $0.454B
Nature's Sunshine Products manufactures and markets through direct sales encapsulated and tableted herbal products, high quality natural vitamins, and other complementary products. In addition to the United States, the Company has operations in Japan, Mexico, Central America, South Korea, Canada, Dominican Republic, Venezuela, Ecuador, Peru, the United Kingdom, Columbia, Brazil, Thailand, Israel, Singapore, Malaysia, Indonesia, the Philippines, Australia, Hong Kong, Taiwan, Russia, Ukraine, Latvia, Lithuania, Kazakhstan, Mongolia, Belarus, China, Poland, Germany, Austria, Norway, Sweden, the Czech Republic and the Netherlands. The Company also has exclusive distribution agreements with selected companies in Argentina, Australia, Chile, New Zealand, and Norway.
Stock Name Country Market Cap PE Ratio
Chugai Pharmaceutical (CHGCY) Japan $85.665B 32.14
Zoetis (ZTS) United States $75.819B 28.29
Daiichi Sankyo, - (DSNKY) Japan $49.559B 25.21
Takeda Pharmaceutical (TAK) Japan $47.633B 9.47
Sandoz Group AG (SDZNY) Switzerland $22.493B 0.00
Merck (MKKGY) Germany $16.918B 12.40
Summit Therapeutics (SMMT) United States $15.314B 0.00
United Therapeutics (UTHR) United States $14.624B 12.94
Shionogi (SGIOY) Japan $14.121B 14.15
Neurocrine Biosciences (NBIX) United States $12.371B 42.37
Orion OYJ (ORINY) Finland $9.913B 26.81
IPSEN (IPSEY) France $9.890B 0.00
Corcept Therapeutics (CORT) United States $7.371B 59.92
Stevanato Group S.p.A (STVN) Italy $6.599B 40.35
Madrigal Pharmaceuticals (MDGL) United States $6.315B 0.00
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $6.153B 0.00
Grifols, S.A (GRFS) Spain $5.734B 0.00
Ionis Pharmaceuticals (IONS) United States $5.532B 0.00
Ono Pharmaceutical (OPHLF) Japan $4.875B 14.83
Soleno Therapeutics (SLNO) United States $3.900B 0.00
Catalyst Pharmaceuticals (CPRX) United States $3.038B 10.65
Crinetics Pharmaceuticals (CRNX) United States $3.006B 0.00
Hypermarcas (HYPMY) Brazil $2.829B 18.61
BioCryst Pharmaceuticals (BCRX) United States $2.342B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $2.335B 12.63
NewAmsterdam Pharma (NAMS) Netherlands $2.098B 0.00
Recursion Pharmaceuticals (RXRX) United States $1.785B 0.00
Centessa Pharmaceuticals (CNTA) United Kingdom $1.784B 0.00
Indivior (INDV) United States $1.748B 7.41
Dyne Therapeutics (DYN) United States $1.508B 0.00
Evotec AG (EVO) Germany $1.431B 0.00
ARS Pharmaceuticals (SPRY) United States $1.427B 0.00
Guardian Pharmacy Services (GRDN) United States $1.380B 0.00
Ocular Therapeutix (OCUL) United States $1.327B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.081B 21.62
Harrow (HROW) United States $1.076B 0.00
Enliven Therapeutics (ELVN) United States $1.073B 0.00
Ardelyx (ARDX) United States $0.940B 0.00
Collegium Pharmaceutical (COLL) United States $0.939B 5.07
Avadel Pharmaceuticals (AVDL) Ireland $0.912B 0.00
Akebia Therapeutics (AKBA) United States $0.898B 0.00
Cronos Group (CRON) Canada $0.744B 0.00
Xeris Biopharma Holdings (XERS) United States $0.727B 0.00
KalVista Pharmaceuticals (KALV) United States $0.664B 0.00
Xencor (XNCR) United States $0.651B 0.00
AleAnna (ANNA) United States $0.631B 0.00
Elite Pharmaceuticals (ELTP) United States $0.577B 0.00
Relay Therapeutics (RLAY) United States $0.564B 0.00
Theravance Biopharma (TBPH) United States $0.556B 0.00
USANA Health Sciences (USNA) United States $0.556B 12.09
Regulus Therapeutics (RGLS) United States $0.552B 0.00
Bioventus (BVS) United States $0.547B 13.88
Zevra Therapeutics (ZVRA) United States $0.485B 0.00
Tourmaline Bio (TRML) United States $0.474B 0.00
Amylyx Pharmaceuticals (AMLX) United States $0.456B 0.00
Oruka Therapeutics (ORKA) United States $0.447B 0.00
Siga Technologies (SIGA) United States $0.443B 9.25
Altimmune (ALT) United States $0.440B 0.00
Verve Therapeutics (VERV) United States $0.431B 0.00
Savara (SVRA) United States $0.415B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.364B 9.85
Organogenesis (ORGO) United States $0.356B 0.00
Aquestive Therapeutics (AQST) United States $0.316B 0.00
Heron Therapeutics (HRTX) United States $0.305B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.296B 0.00
MediWound (MDWD) Israel $0.233B 0.00
ProKidney (PROK) United States $0.228B 0.00
Esperion Therapeutics (ESPR) United States $0.208B 0.00
Nanobiotix S.A (NBTX) France $0.193B 0.00
4D Molecular Therapeutics (FDMT) United States $0.179B 0.00
Journey Medical (DERM) United States $0.168B 0.00
OmniAb (OABI) United States $0.167B 0.00
Profound Medical (PROF) Canada $0.165B 0.00
Aclaris Therapeutics (ACRS) United States $0.159B 0.00
Avita Medical (RCEL) United States $0.155B 0.00
Larimar Therapeutics (LRMR) United States $0.154B 0.00
Enanta Pharmaceuticals (ENTA) United States $0.154B 0.00
Inhibikase Therapeutics (IKT) United States $0.151B 0.00
Achieve Life Sciences (ACHV) Canada $0.146B 0.00
Aldeyra Therapeutics (ALDX) United States $0.141B 0.00
Nektar Therapeutics (NKTR) United States $0.139B 0.00
Liminatus Pharma (LIMN) $0.138B 0.00
Wellgistics Health (WGRX) United States $0.134B 0.00
Protara Therapeutics (TARA) United States $0.127B 0.00
Innate Pharma SA (IPHYF) France $0.122B 0.00
Lyell Immunopharma (LYEL) United States $0.118B 0.00
Korro Bio (KRRO) United States $0.112B 0.00
Cardiol Therapeutics (CRDL) Canada $0.108B 0.00
Cassava Sciences (SAVA) United States $0.104B 0.00
Inotiv (NOTV) United States $0.102B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.102B 0.00
Ironwood Pharmaceuticals (IRWD) United States $0.099B 0.00
OptiNose (OPTN) United States $0.097B 0.00
Fractyl Health (GUTS) United States $0.096B 0.00
VAXART, INC (VXRT) United States $0.095B 0.00
Lexeo Therapeutics (LXEO) United States $0.094B 0.00
Unicycive Therapeutics (UNCY) United States $0.092B 0.00
Champions Oncology (CSBR) United States $0.089B 14.61
Arch Biopartners (ACHFF) Canada $0.087B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.086B 64.22
Nutriband (NTRB) United States $0.086B 0.00
Pyxis Oncology (PYXS) United States $0.082B 0.00
Galectin Therapeutics (GALT) United States $0.082B 0.00
ESSA Pharma (EPIX) Canada $0.076B 0.00
Surrozen (SRZN) United States $0.072B 0.00
Vivani Medical (VANI) United States $0.068B 0.00
Metagenomi (MGX) United States $0.066B 0.00
Assertio Holdings (ASRT) United States $0.064B 0.00
Dominari Holdings (DOMH) United States $0.064B 0.00
Telomir Pharmaceuticals (TELO) United States $0.061B 0.00
Gain Therapeutics (GANX) United States $0.060B 0.00
Allergy Therapeutics (AGYTF) United Kingdom $0.059B 0.00
Prelude Therapeutics (PRLD) United States $0.053B 0.00
Context Therapeutics (CNTX) United States $0.052B 0.00
Century Therapeutics (IPSC) United States $0.049B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.049B 0.00
PMV Pharmaceuticals (PMVP) United States $0.048B 0.00
Avalo Therapeutics (AVTX) United States $0.048B 0.00
NRx Pharmaceuticals (NRXP) United States $0.047B 0.00
Mural Oncology (MURA) Ireland $0.045B 0.00
ElectroCore (ECOR) United States $0.038B 0.00
Iterum Therapeutics (ITRM) Ireland $0.038B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.038B 0.00
Karyopharm Therapeutics (KPTI) United States $0.037B 0.00
Lyra Therapeutics (LYRA) United States $0.037B 0.00
Acrivon Therapeutics (ACRV) United States $0.036B 0.00
Rafael Holdings (RFL) United States $0.035B 0.00
SCYNEXIS (SCYX) United States $0.034B 0.00
PolyPid (PYPD) Israel $0.032B 0.00
FibroGen (FGEN) United States $0.030B 0.00
Jupiter Neurosciences (JUNS) United States $0.028B 0.00
Tempest Therapeutics (TPST) United States $0.025B 0.00
Relmada Therapeutics (RLMD) United States $0.023B 0.00
CASI Pharmaceuticals (CASI) China $0.023B 0.00
Enlivex Therapeutics (ENLV) Israel $0.022B 0.00
Natural Alternatives (NAII) United States $0.021B 0.00
BioVie (BIVI) United States $0.021B 0.00
China SXT Pharmaceuticals (SXTC) China $0.021B 0.00
Mannatech (MTEX) United States $0.020B 0.00
DURECT (DRRX) United States $0.018B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.017B 0.00
Lipocine (LPCN) United States $0.017B 0.00
ProPhase Labs (PRPH) United States $0.016B 0.00
VYNE Therapeutics (VYNE) United States $0.015B 0.00
BioLineRx (BLRX) Israel $0.014B 0.00
Vivos Therapeutics (VVOS) United States $0.014B 0.00
GlycoMimetics (GLYC) United States $0.013B 0.00
Ainos (AIMD) United States $0.013B 0.00
Cosmos Health (COSM) United States $0.013B 0.00
TherapeuticsMD (TXMD) United States $0.013B 0.00
Minerva Neurosciences (NERV) United States $0.012B 2.14
Kiora Pharmaceuticals (KPRX) United States $0.012B 0.00
Ernexa Therapeutics (ERNA) United States $0.011B 0.00
Scienture Holdings (SCNX) United States $0.011B 0.00
Mangoceuticals (MGRX) United States $0.011B 0.00
Traws Pharma (TRAW) United States $0.010B 0.00
Phio Pharmaceuticals (PHIO) United States $0.010B 0.00
Talphera (TLPH) United States $0.010B 0.00
SHINECO (SISI) China $0.010B 0.00
Addex Therapeutics (ADXN) Switzerland $0.009B 0.00
Citius Pharmaceuticals (CTXR) United States $0.009B 0.00
Biomerica (BMRA) United States $0.008B 0.00
NLS Pharmaceutics (NLSP) Switzerland $0.008B 0.00
Nuvilex (PMCB) United States $0.008B 0.00
Carisma Therapeutics (CARM) United States $0.007B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.007B 0.00
Plus Therapeutics (PSTV) United States $0.006B 0.00
TransCode Therapeutics (RNAZ) United States $0.006B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.006B 0.00
Klotho Neurosciences (KLTO) United States $0.006B 0.00
Incannex Healthcare (IXHL) Australia $0.006B 0.00
Indaptus Therapeutics (INDP) United States $0.006B 0.00
Aptorum Group (APM) United Kingdom $0.006B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.005B 0.00
Xenetic Biosciences (XBIO) United States $0.005B 0.00
Alaunos Therapeutics (TCRT) United States $0.005B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.004B 0.00
Redhill Biopharma (RDHL) Israel $0.004B 0.00
Jaguar Animal Health (JAGX) United States $0.004B 0.00
PainReform (PRFX) Israel $0.004B 0.00
Clearmind Medicine (CMND) Canada $0.004B 0.00
InMed Pharmaceuticals (INM) Canada $0.004B 0.00
CERo Therapeutics Holdings (CERO) United States $0.004B 0.00
XORTX Therapeutics (XRTX) Canada $0.004B 0.00
Heatwurx (PCSA) United States $0.003B 0.00
SciSparc (SPRC) Israel $0.003B 0.00
Aditxt (ADTX) United States $0.003B 0.00
Qualigen Therapeutics (QLGN) United States $0.003B 0.00
Conduit Pharmaceuticals (CDT) United States $0.003B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.002B 0.00
TNF Pharmaceuticals (TNFA) United States $0.002B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.002B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.002B 0.00
Universe Pharmaceuticals INC (UPC) China $0.000B 0.00
4D Pharma (LBPS) United Kingdom $0.000B 0.00
MEI Pharma (MEIP) United States $0.000B 0.00
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00
Silence Therapeutics (SLN) United Kingdom $0.000B 0.00